Exploring factors affected timely receiving intravitreal anti-VEGF treatment in patients with Diabetic Macular Edema: a qualitative interview study analyzed with COM-B model

1.1. Design and setting

A larger, three-phased mixed methods study is being conducted to develop a theory-based intervention to improve adherence to anti-VEGF treatment in patients with DME. This present study was Phase 1 to use a theoretical framework to identify the factors that influence intravitreal injection of anti-VEGF agents. We used a qualitative descriptive design to conduct semi-structured interviews with patients undergoing anti-VEGF treatment. The research was performed consistently with a reporting framework of Consolidated Criteria for Reporting Qualitative Research.

Ethical approval for the study protocol was obtained from the ethics committees of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (No. 2022-KY-021).

1.2. Recruitment of participants

Convenience sampling was used to recruit the participants from seven provinces in China between February and May 2022 to represent different patient demographics and access to anti-VEGF treatment. The eligibility criteria for participants were as follows: (1) aged ≥ 18 years; (2) diagnosis of DME and at least one prior intravitreal injection of anti-VEGF agents; (3) the ability to communicate in Chinese. We selected patients of different ages, literacy levels, sexes, and diagnoses to ensure a broad selection.

1.3. Data collection

The study team developed an interview guide to better understand patient’s perspectives on anti-VEGF treatment based on the TDF (Table 1). Before the interview, participants were informed of the purpose of the study and the content of the interview and signed written informed consent.

Semi-structured interviews by face-to-face or telephone were conducted by an experienced qualitative researcher (LS) who received initial and ongoing qualitative training from Shanghai Jiao Tong University School of Nursing and by another senior qualitative researcher (XY) and were audio-recorded and transcribed verbatim within 24 hours. The transcripts were given to the participants for any corrections or comments to clarify unclear answers. We also conducted a brief demographic survey at the beginning of each interview.

1.4. Data Analysis

Participants were numbered according to the interview order (Participant 1, Participant 2…). The transcripts were coded independently by two researchers (PJN, TSY). Then the thematic analysis was conducted to analyze the data by Colaizzi, following (1) read all the interview materials carefully, (2) extracted important statements in line with the study phenomenon, (3) encoded recurring important statements, (4) gathered the encoded statements, (5) wrote a detailed and complete description, (6) identified the similar statements and (7) returned to the participants to verify the authenticity of the content. The research team constantly compared the analysis and results to ensure accuracy.

2.1. Participant characteristics

The study engaged 24 participants (Table 2), with city coverage Tier 1-3, Tier 4 and county city. Mean interview time was 45min (range 35-75min).

2.2. Summary of themes and subthemes

Eleven subthemes emerged from the COM-B domains are shown in Table 3.

3.1. Capability factors

Lack of knowledge and high treatment expenditure were major barriers to timely receiving anti-VEGF treatment, categorized into the ‘capability’ theme. The majority of participants in our study were retirees with junior high school educational level, which led to the lack of sufficient knowledge of disease and influenced their decision on treatment. Thus, when something wrong with their eyes, they thought it was the normal aging process or ‘with cataract’. Disease knowledge play an important role in seeking treatment and changing behavior[12,13]. Lack of knowledge adversely affected the patient’s outcomes[14], and can be improved by providing disease knowledge education which can be added to pre-injection counseling. Meanwhile, patient’s knowledge about disease and medication, and patient expectations about the treatment outcome may also influence their adherence and persistence[15,16].

Some participants even thought ‘prioritized glycemic control rather than anti-VEGF’. This result might be attributed to the follow reasons: (1) Diagnosed with DME was earlier than diabetes, in other words, until the patient was diagnosed with DME, he found that he had diabetes. (2) Lack of knowledge of fundus disease. In China, public awareness of cataract is much higher than other eye diseases due to the popularization of cataract surgery and policy support. This is why participants always think that they had ‘cataract’.

Although medical insurance paid for partial treatment costs, some participants still felt that the remaining were too expensive to afford, which was another major obstacle to timely treatment, which was consistent with other studies[17], only 15% of the out-of-pocket expenditure patients reported high adherence to medication[18].

3.2. Opportunity factors

In our study, we found that some physical opportunities might lead to delayed diagnosis, untimely treatment and follow-up.

Some participants mentioned anti-VEGF injection was not available in their hometown and chose alternative treatment. Until symptoms were more severe than before, they finally referred to other hospitals to receive treatment. Lack of access to health-care services decreased adherence[16]. In China, intravitreal anti-VEGF injection was only available in tertiary hospitals where the costs can be paid by Chinese medical insurance.

‘Recommend eyedrops, laser and oral drug but not mentioned intravitreal anti-VEGF injection’, ‘as an optional therapy, selected more convenient treatment rather than anti-VEGF agents’ and ‘no confidence in treatment from doctor’ were all the obstacles to timely treatment. Some participants had to refer to other hospitals, after making sure anti-VEGF treatment was the optimal one, they received injection immediately. All of them expressed the need for doctor’s authoritative advice on intravitreal anti-VEGF injection and detailed introduction to the injection process which can help them receive standard treatment earlier. Individuals’ preferences are strongly affected by the way in which choices are presented[19].Some participants mentioned that it was difficult to communicate with doctors. Communication was identified as one of the most significant obstacles in terms of the subtheme “physical opportunity”[20]. Most patients in China went directly to tertiary hospitals regardless of the severity or type of disease, leading to an excessive clinical workload for doctors in tertiary hospitals[21], the accumulation of patients also leads to long waiting time and short reception time, and make doctors have no much time to give detailed explanation, the feeling of rushed by doctors made it difficult for patients to raise all their concerns or ask questions, which was consistent with other research where patients expressed a desire for longer consultations with their clinicians[22,23]. Other studies have found that multiple visits with a clinician can generate trust and comfort, and long-term relationships can promote patient participation[24]. Intravitreal anti-VEGF injection in patients with DME was not a one-time treatment, and needed a long-time regular follow-up and treatment, thus, effective communication and comfortable relationship play a crucial role[21].

3.3. Motivation factors

In terms of reflective motivation educed the subthemes ‘outcome expectancy’. Participants worried about the deterioration of vision acuity impacted on their daily life, which were the primary incentive to anti-VEGF treatment. Higher outcome expectancy was associated with higher self-management[25], adherence[26,27] and lower depression[27]. Therefore, we should attach importance to patient’s outcome expectancy and relations between it and adherence.

We also discovered two subthemes ‘fear of blindness’ and ‘fear of injection’ were partial causes for untimely treatment. ‘Fear of blindness’ made participants willing to injection, but meanwhile, ‘fear of injection’ made the refusing to injection. Therefore, timely alleviation of anxiety and fear of injection are crucial to the success of treatment, which requires a combination of assessment, education and behavioral intervention[28,29].

3.4. Limitation

This study only recruited patients with DME who received intravitreal anti-VEGF injection, and other clinical variables such as the severity and duration of disease, as well as other treatments patients, were not included. Despite these potential limitations, the strengths of our study included using the COM-B framework to guide the development of interview and analysis the results, enabling us to understand the factors affect patient’s behavior of intravitreal anti-VEGF injection, and providing evidence for optimizing the process of pre-injection counseling in order to accelerate decision-making and improve treatment adherence.